Innovadora prueba de saliva se lanza en Israel para detectar docenas de enfermedades hereditarias
La prueba única en la vida examina 173 genes vinculados a cánceres hereditarios, afecciones cardiovasculares, enfermedades metabólicas y otros trastornos graves
Valoración
A new saliva-based genetic screening is now available in Israel, covering 173 genes tied to serious hereditary conditions including certain cancers and heart diseases. The test is described as a one-time procedure, which may reshape how hereditary risk is evaluated across the population. The key question is how this tool will be integrated into existing healthcare routines and who will have access to it.